Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

GMP in India

How Schedule M Revised Impacts the Manufacturing and Packaging of Vaccines in India

Posted on February 10, 2025 By digi

How Schedule M Revised Impacts the Manufacturing and Packaging of Vaccines in India The Influence of Schedule M Revised on Vaccine Manufacturing and Packaging Processes in India Introduction to Schedule M Revised and Vaccine Manufacturing The revised Schedule M under the Drugs and Cosmetics Rules, 1945, has brought significant advancements to the pharmaceutical manufacturing industry…

Read More “How Schedule M Revised Impacts the Manufacturing and Packaging of Vaccines in India” »

GMP in India

How Schedule M Revised Affects Pharmaceutical Waste Management and Disposal

Posted on February 11, 2025 By digi

How Schedule M Revised Affects Pharmaceutical Waste Management and Disposal Understanding the Impact of Schedule M Revised on Pharmaceutical Waste Management and Disposal Introduction to Pharmaceutical Waste Management and Schedule M Revised Pharmaceutical manufacturing generates a wide range of waste, including chemical, biological, and packaging materials, which, if not managed properly, can pose significant risks…

Read More “How Schedule M Revised Affects Pharmaceutical Waste Management and Disposal” »

GMP in India

The Role of Corrective and Preventive Actions (CAPA) in Ensuring Schedule M Revised Compliance

Posted on February 11, 2025 By digi

The Role of Corrective and Preventive Actions (CAPA) in Ensuring Schedule M Revised Compliance Tips for Implementing Effective CAPA Systems for Schedule M Revised Compliance Introduction to CAPA and Schedule M Revised Corrective and Preventive Actions (CAPA) are vital components of Good Manufacturing Practices (GMP), ensuring continuous improvement and compliance in pharmaceutical manufacturing. Under Schedule…

Read More “The Role of Corrective and Preventive Actions (CAPA) in Ensuring Schedule M Revised Compliance” »

GMP in India

How to Ensure Compliance with Schedule M Revised for Pharmaceutical Exports

Posted on February 12, 2025 By digi

How to Ensure Compliance with Schedule M Revised for Pharmaceutical Exports A Step-by-Step Guide to Achieving Schedule M Revised Compliance for Pharmaceutical Exports Introduction to Schedule M Revised and Pharmaceutical Exports With the globalization of the pharmaceutical industry, ensuring compliance with international quality standards has become essential for manufacturers aiming to export their products. Schedule…

Read More “How to Ensure Compliance with Schedule M Revised for Pharmaceutical Exports” »

GMP in India

The Importance of Validating Processes and Procedures for Schedule M Revised Compliance

Posted on February 12, 2025 By digi

The Importance of Validating Processes and Procedures for Schedule M Revised Compliance Why Validating Processes and Procedures is Crucial for Schedule M Revised Compliance Introduction to Process Validation and Schedule M Revised In pharmaceutical manufacturing, the validation of processes and procedures is critical for ensuring consistent product quality and compliance with regulatory standards. The revised…

Read More “The Importance of Validating Processes and Procedures for Schedule M Revised Compliance” »

GMP in India

How Schedule M Revised Impacts the Testing and Release of Pharmaceutical Products in India

Posted on February 13, 2025 By digi

How Schedule M Revised Impacts the Testing and Release of Pharmaceutical Products in India Expert Insights on Testing and Releasing Pharmaceutical Products Under Schedule M Revised Introduction to Testing and Release Requirements Under Schedule M Revised Pharmaceutical manufacturing demands rigorous quality checks to ensure that products meet safety, efficacy, and compliance standards. The Schedule M…

Read More “How Schedule M Revised Impacts the Testing and Release of Pharmaceutical Products in India” »

GMP in India

How to Prepare for a Schedule M Revised GMP Inspection in India

Posted on February 13, 2025 By digi

How to Prepare for a Schedule M Revised GMP Inspection in India Step-by-Step Preparation for Schedule M Revised GMP Inspections Introduction to Schedule M Revised GMP Inspections The revised Schedule M under the Drugs and Cosmetics Rules, 1945, has introduced stricter Good Manufacturing Practices (GMP) guidelines for pharmaceutical manufacturers in India. Regulatory inspections are conducted…

Read More “How to Prepare for a Schedule M Revised GMP Inspection in India” »

GMP in India

The Role of Data Integrity in Compliance with Schedule M Revised for Indian Pharmaceutical Manufacturers

Posted on February 14, 2025 By digi

The Role of Data Integrity in Compliance with Schedule M Revised for Indian Pharmaceutical Manufacturers How Data Integrity Drives Compliance with Schedule M Revised in Pharmaceutical Manufacturing Introduction to Data Integrity and Schedule M Revised Data integrity is a cornerstone of Good Manufacturing Practices (GMP) and plays a pivotal role in ensuring compliance with regulatory…

Read More “The Role of Data Integrity in Compliance with Schedule M Revised for Indian Pharmaceutical Manufacturers” »

GMP in India

How Schedule M Revised Contributes to the Overall Quality Assurance of Indian Pharmaceutical Products

Posted on February 15, 2025 By digi

How Schedule M Revised Contributes to the Overall Quality Assurance of Indian Pharmaceutical Products The Role of Schedule M Revised in Strengthening Quality Assurance for Indian Pharmaceuticals Introduction to Schedule M Revised and Quality Assurance The revised Schedule M under the Drugs and Cosmetics Rules, 1945, has transformed Good Manufacturing Practices (GMP) in the Indian…

Read More “How Schedule M Revised Contributes to the Overall Quality Assurance of Indian Pharmaceutical Products” »

GMP in India

Future Trends in Schedule M Revised Compliance and Its Impact on the Indian Pharmaceutical Industry

Posted on February 15, 2025 By digi

Future Trends in Schedule M Revised Compliance and Its Impact on the Indian Pharmaceutical Industry Emerging Trends in Schedule M Revised Compliance and Their Influence on Indian Pharmaceuticals Introduction to Schedule M Revised Compliance The revised Schedule M under the Drugs and Cosmetics Rules, 1945, has redefined Good Manufacturing Practices (GMP) for the Indian pharmaceutical…

Read More “Future Trends in Schedule M Revised Compliance and Its Impact on the Indian Pharmaceutical Industry” »

GMP in India

Posts pagination

Previous 1 … 4 5 6 Next

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme